CSE:HYTN - Post Discussion
Post by
Betteryear2 on May 01, 2024 9:24am
HYTN Welcomes U.S. Recommendation to Reclassify Cannabis
VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN “HYTN” or “The Company”), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds including cannabis, applauds the recent formal recommendation by the U.S. Justice Department, endorsed by the Drug Enforcement Agency (DEA), to reclassify cannabis from a Schedule I to a Schedule III controlled substance. HYTN Welcomes U.S. Recommendation to Reclassify Cannabis, (globenewswire.com)
Be the first to comment on this post